Saturday, December 27, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Almonty Stock Faces Critical Market Test

Robert Sasse by Robert Sasse
November 11, 2025
in Analysis, Commodities, Nasdaq, Penny Stocks
0
Almonty Stock
0
SHARES
201
VIEWS
Share on FacebookShare on Twitter

Almonty Industries confronts a pivotal moment as 120-day lock-up restrictions from its July Nasdaq listing are set to expire, potentially flooding the market with additional shares. This comes amid contrasting signals from market analysts who have recently upgraded their outlook on the tungsten producer, creating a potentially volatile scenario for investors.

Lock-Up Expiration Creates Supply Pressure

Trading restrictions on various Almonty securities—including warrants, convertible bonds, and shares held by directors and management—expire today. These limitations were established on July 14, 2025, as part of the company’s successful $90 million Nasdaq Capital Market listing.

While Almonty shares gained 2.14% to reach $7.15 on November 10, they remain below recent peak levels. The stock’s performance this year has been remarkable, surging over 400% since January, driven primarily by tungsten prices reaching multi-year highs between $580 and $645 per metric ton.

Strong Profit Turnaround Despite Revenue Shortfall

Almonty’s third-quarter results, released November 3, revealed a dramatic financial turnaround. The company reported net earnings of $33.2 million (diluted EPS: $0.13), a substantial improvement from the $5.3 million loss recorded during the same period last year. This reversal was largely powered by a $34.5 million gain from the revaluation of warrant liabilities.

Revenue increased 28% to $8.7 million, though this figure fell short of FactSet’s $11.3 million estimate. The revenue growth was attributed to stronger tungsten pricing and consistent production output from the Panasqueira mine in Portugal.

The company’s liquidity position strengthened significantly, with cash reserves swelling to $111.6 million as of September 30, 2025, compared to just $7.8 million at the end of 2024.

Should investors sell immediately? Or is it worth buying Almonty?

Analyst Confidence Remains Strong

Despite the revenue disappointment, financial analysts have maintained bullish positions on Almonty. B. Riley Securities raised its price target from $7 to $10 while reaffirming its buy recommendation, citing growing confidence in the company’s strategic positioning ahead of the completion of its Sangdong mine in South Korea.

Diamond Equity Research set an even more optimistic target of C$11 per share, pointing to strengthened tungsten prices and reduced execution risk following the Nasdaq listing.

Geopolitical Tensions Enhance Tungsten’s Strategic Value

Almonty stands to benefit from escalating geopolitical tensions that have positioned tungsten as a critical strategic mineral. As a leading non-Chinese tungsten supplier, the company is well-placed to serve defense and high-technology supply chains.

Construction of the Sangdong mine—destined to become the largest tungsten operation in the Western world—is nearing completion. In October, Almonty expanded its portfolio with the $10 million acquisition of the Genting Browns Lake project in Montana, with U.S. production expected to commence in the second half of 2026.

Industry specialists anticipate structural support for tungsten prices in the $400-$450 per metric ton range, driven by constrained supply outside China and increasing defense sector demand.

Ad

Almonty Stock: Buy or Sell?! New Almonty Analysis from December 27 delivers the answer:

The latest Almonty figures speak for themselves: Urgent action needed for Almonty investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 27.

Almonty: Buy or sell? Read more here...

Tags: Almonty
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

AMD Stock
AI & Quantum Computing

AMD’s Billion-Dollar China Opportunity Meets Investor Caution

December 27, 2025
Adobe Stock
Analysis

Adobe Stock: Diverging Views Highlight Strategic Crossroads

December 27, 2025
Intel Stock
Analysis

Intel’s Remarkable Resurgence: A Critical Juncture in 2025

December 27, 2025
Next Post
Nestle Stock

Is Nestlé Stock Signaling a Sustained Recovery?

Healwell AI Stock

Healwell AI Shares Face Mounting Analyst Pessimism

Lynas Stock

Lynas Receives Dual Boost with Index Inclusion and License Progress

Recommended

QuantumScape Stock

QuantumScape Leadership Exodus Sparks Investor Concerns

1 month ago
Clean Energy Fuels Stock

Clean Energy Fuels Navigates a Mixed Outlook in the Renewable Gas Sector

4 months ago
Tempus AI Stock

Tempus AI: Market Experts Divided as Healthcare Innovator Posts First Profit

1 month ago
Omnicell Stock

Omnicell Shares Face Persistent Selling Pressure Despite Solid Earnings

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Novo Nordisk Shares Signal a Turnaround with Key FDA Approval

Rocket Lab Shares Pull Back Following Record Rally

Institutional Buyers See Opportunity in PepsiCo’s Recent Stock Weakness

Realty Income Shares Pause Near Peak Levels

Broadcom’s Margin Outlook Overshadows Record AI Revenue

Tesla’s AI Ambitions Face Reality Check Amid Operational Hurdles

Trending

AMD Stock
AI & Quantum Computing

AMD’s Billion-Dollar China Opportunity Meets Investor Caution

by Robert Sasse
December 27, 2025
0

Advanced Micro Devices (AMD) is navigating a complex landscape of significant opportunity and growing market skepticism. The...

Adobe Stock

Adobe Stock: Diverging Views Highlight Strategic Crossroads

December 27, 2025
Intel Stock

Intel’s Remarkable Resurgence: A Critical Juncture in 2025

December 27, 2025
Novo Nordisk Stock

Novo Nordisk Shares Signal a Turnaround with Key FDA Approval

December 27, 2025
Rocket Lab USA Stock

Rocket Lab Shares Pull Back Following Record Rally

December 27, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • AMD’s Billion-Dollar China Opportunity Meets Investor Caution
  • Adobe Stock: Diverging Views Highlight Strategic Crossroads
  • Intel’s Remarkable Resurgence: A Critical Juncture in 2025

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com